Insights into the Effects of Complement Factor H on the Assembly and Decay of the Alternative Pathway C3
Serena Bettoni1, Elena Bresin1, Giuseppe Remuzzi2
1From the IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Clinical Research Center for Rare Diseases Aldo e Cele Daccò, 24020 Ranica, Bergamo.
Insights
Factor H (FH) does not prevent C3bB assembly but inhibits its conversion to C3bBb. FH accelerates C3bBb decay, impacting complement alternative pathway regulation.
Area of Science:
- Immunology
- Biochemistry
Background:
- The complement alternative pathway is crucial for innate immunity.
- Factor H (FH) is a key regulator, but its precise role in C3 proconvertase (C3bB) and C3 convertase (C3bBb) formation and decay is not fully understood.
- Previous studies suggest FH competes with factor B for C3b binding, but this has not been thoroughly investigated regarding C3bB assembly.
Purpose of the Study:
- To investigate the effect of Factor H (FH) on the assembly, decay, and formation of complement C3 proconvertase (C3bB) and C3 convertase (C3bBb).
- To clarify the mechanism by which FH regulates the alternative complement pathway.
Main Methods:
- Development of user-friendly assays combining microplate and Western blotting techniques.
- Specific detection of C3bB and C3bBb complexes.
- Investigation of FH's impact on C3bB/C3bBb assembly, decay, and formation.
Main Results:
- FH does not affect C3bB assembly, indicating it does not efficiently compete with factor B for C3b binding.
- FH does not dissociate pre-formed C3bB complexes.
- FH exhibits strong C3bBb decay-accelerating activity and inhibits C3bBb formation by preventing the conversion of C3bB to C3bBb.
- FH prevents the release of factor Bb (Ba) subunit from C3bB, suggesting inhibition of C3bB to C3bBb conversion.
Conclusions:
- FH's inhibitory effect on C3bBb formation is a combination of inhibiting C3bB conversion to C3bBb and accelerating C3bBb decay.
- FH does not prevent C3bB assembly but regulates downstream convertase formation and stability.
- Further cell-based studies are needed to confirm these findings in physiological settings.
Abstract:
The activated fragment of C3 (C3b) and factor B form the C3 proconvertase (C3bB), which is cleaved by factor D to C3 convertase (C3bBb). Older studies (Conrad, D. H., Carlo, J. R., and Ruddy, S. (1978)J. Exp. Med.147, 1792-1805; Pangburn, M. K., and Müller-Eberhard, H. J. (1978)Proc. Natl. Acad. Sci. U.S.A.75, 2416-2420; Kazatchkine, M. D., Fearon, D. T., and Austen, K. F. (1979)J. Immunol.122, 75-81) indicated that the complement alternative pathway regulator factor H (FH) competes with factor B for C3b binding; however, the capability of FH to prevent C3bB assembly has not been formally investigated. Moreover, in the few published studies FH did not favor C3bB dissociation. Whether FH may affect C3bBb formation from C3bB is unknown. We set up user-friendly assays based on combined microplate/Western blotting techniques that specifically detect either C3bB or C3bBb, with the aim of investigating the effect of FH on C3bB assembly and decay and C3bBb formation and decay. We document that FH does not affect C3bB assembly, indicating that FH does not efficiently compete with factor B for C3b binding. We also found that FH does not dissociate C3bB. FH showed a strong C3bBb decay-accelerating activity, as reported previously, and also exerted an apparent inhibitory effect on C3bBb formation. The latter effect was not fully attributable to a rapid FH-mediated dissociation of C3bBb complexes, because blocking decay with properdin and C3 nephritic factor did not restore C3bBb formation. FH almost completely prevented release of the smaller cleavage subunit of FB (Ba), without modifying the amount of C3bB complexes, suggesting that FH inhibits the conversion of C3bB to C3bBb. Thus, the inhibitory effect of FH on C3bBb formation is likely the sum of inhibition of C3bB conversion to C3bBb and of C3bBb decay acceleration. Further studies are required to confirm these findings in physiological cell-based settings.
Related Concept Videos
Complement System
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Caspases
Clot Retraction and Fibrinolysis
Anticoagulant Drugs: Low-Molecular-Weight Heparins


